Statistical Analysis Code: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF TAMOXIFEN COMBINED WITH AMPHOTERICIN B AND FLUCONAZOLE FOR CRYPTOCOCCAL MENINGITIS by Ngan, N, Day, J, Le, N

Subjects:

With No Lysine Kinase 3 (WNK3); A Target Enabling Package by Bullock, A

“…Gain of function mutations in WNK kinases are found in Gordon’s hypertension syndrome suggesting the WNK pathway as a therapeutic target. WNK3 inhibition in particular has also been shown to reduce cerebral injury after Ischemic stroke. …”

With No Lysine Kinase 3 (WNK3); A Target Enabling Package by Pinkas, D

“…Gain of function mutations in WNK kinases are found in Gordon’s hypertension syndrome suggesting the WNK pathway as a therapeutic target. WNK3 inhibition in particular has also been shown to reduce cerebral injury after Ischemic stroke. …”

With no lysine kinase 3 (WNK3); A Target Enabling Package by Pinkas, D

“…Gain of function mutations in WNK kinases are found in Gordon’s hypertension syndrome suggesting the WNK pathway as a therapeutic target. WNK3 inhibition in particular has also been shown to reduce cerebral injury after Ischemic stroke. …”

Sonoluminescence from microbubbles at 1 MHz by Beguin, E

“…This could be exploited both for diagnostic and therapeutic applications, significantly increasing the range of applications that are currently restricted by the limited penetration of light in the tissue.…”

LIM domain kinase 1 (LIMK1), human kinase domain; A Target Enabling Package by Mathea, S

“…Here we present a target enabling package for the therapeutic target LIMK1. We include crystal structures of BMPR2, LIMK1, LIMK2 and the LIMK1-cofilin complex, as well as multiple assays for small molecule inhibitor screening. …”

LIM Domain Kinase 1 (LIMK1), Human Kinase Domain; A Target Enabling Package by Bullock, A

“…Here we present a target enabling package for the therapeutic target LIMK1. We include crystal structures of BMPR2, LIMK1, LIMK2 and the LIMK1-cofilin complex, as well as multiple assays for small molecule inhibitor screening. …”

LIM Domain Kinase 1 (LIMK1), human kinase domain; A Target Enabling Package by Mathea, S

“…Here we present a target enabling package for the therapeutic target LIMK1. We include crystal structures of BMPR2, LIMK1, LIMK2 and the LIMK1-cofilin complex, as well as multiple assays for small molecule inhibitor screening. …”

Books, Minds, and Bodies: raw transcript text plus VAD values by Carney, J P, Troscianko, E T, Holman, E

“…The project was designed to investigate the therapeutic potential of shared reading, and involved running 2 reading groups over 2 consecutive terms and recording participants' discussions of the texts being read aloud together. …”

Books, Minds, and Bodies dataset by Troscianko, E, Carney, J, Holman, E

“…The project was designed to investigate the therapeutic potential of shared reading, and involved running 2 reading groups over 2 consecutive terms and recording participants' discussions of the texts being read aloud together. …”

Sonothrombolysis with magnetically targeted microbubbles by de Saint Victor, M

“…There are 5 sections: 1) Magnetic field caracterisation: magnitude of the magnetic field and of the magnetic field gradient in the experimental setup (used in figure 2) 2) Accumulation of magnetic material in the focal region with and without a magnet (used in figure 3) 3) Lysis rates (used in figures 4 and 8) 4) Acoustic energy detected (used in figures 7 and 8) 5) Clot debris sizing Microbubble-enhanced sonothrombolysis is a promising approach to increase the safety and efficacy of current pharmacological treatments for ischemic stroke. Maintaining therapeutic concentrations of microbubbles and drugs at the clot site however poses a challenge. …”

'Hepitopes': A Database of HLA Class I Epitopes in Hepatitis B Virus (HBV) by Matthews, P

“…For these reasons, increased clinical and scientific scrutiny is being applied to develop new therapeutic approaches with an ultimate goal of achieving cure. …”